Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Aurobindo Pharma Ltd (Aurobindo) is a vertically integrated pharmaceutical company that manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs). Its product portfolio is spread across major therapeutic and product categories including antibiotics, anti-retroviral, systemic gastroenterological, central nervous system, cardiovascular, anti-allergies, anti-diabetics, other therapeutic areas. The company also produces novel proprietary biocatalysts, vitamins, minerals, dietary supplements, sports nutrition, functional foods, weight loss products and fermentation-based semi-synthetic products. Aurobindo operates manufacturing facilities in India, Brazil, Portugal and the US; and R&D facilities in India and the US. The company exports products to several countries worldwide. Aurobindo is headquartered in Hyderabad, Telangana, India.Aurobindo Pharma Ltd Key Recent Developments
- Aug 12, 2023: AUROBINDO PHARMA LTD. -- Outcome Of Board Meeting
- Jul 28, 2023: Aurobindo Pharma Notice of AGM
- Jul 21, 2023: Aurobindo Pharma : Completion of US FDA Inspection at our Unit III - Reg
- Jun 29, 2023: Auro PR Inc, Puerto Rico Is Undertaking a Restructuring of Its Facility to Enhance Production Volume
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Torrent Pharmaceuticals Ltd
- Alkem Laboratories Ltd
- Divi's Laboratories Ltd
- Lupin Ltd
- Sun Pharmaceutical Industries Ltd
- Dr. Reddy's Laboratories Ltd
- Emcure Pharmaceuticals Ltd
- Cipla Ltd
- Zydus Lifesciences Ltd
- Viatris Inc
- Lupin Ltd
- Sun Pharmaceutical Industries Ltd
- Divi's Laboratories Ltd
- Alkem Laboratories Ltd
- Emcure Pharmaceuticals Ltd
- Dr. Reddy's Laboratories Ltd
- Torrent Pharmaceuticals Ltd
- Viatris Inc
- Zydus Lifesciences Ltd
- Cipla Ltd